Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Improved screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test

Susana Eyheramendy, View ORCID ProfilePedro A. Saa, View ORCID ProfileEduardo A. Undurraga, Carlos Valencia, Carolina López, Luis Méndez, Javier Pizarro-Berdichevsky, Andrés Finkelstein-Kulka, Sandra Solari, Nicolás Salas, Pedro Bahamondes, Martín Ugarte, Pablo Barceló, Marcelo Arenas, Eduardo Agosin
doi: https://doi.org/10.1101/2021.01.18.21249821
Susana Eyheramendy
aFaculty of Engineering and Science, Universidad Adolfo Ibáñez, Santiago, Chile
bMillennium Institute for Foundational Research on Data (IMFD), Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro A. Saa
cDepartment of Chemical and Bioprocess Engineering, School of Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile
dInstitute for Mathematical and Computational Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pedro A. Saa
Eduardo A. Undurraga
eSchool of Government, Pontificia Universidad Católica de Chile, Santiago, Chile
fMillennium Initiative for Collaborative Research in Bacterial Resistance (MICROB-R), Santiago, Chile
gResearch Center for Integrated Disaster Risk Management (CIGIDEN), Santiago, Chile
hCanadian Institute for Advanced Research (CIFAR), Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eduardo A. Undurraga
Carlos Valencia
iCenter for Aromas and Flavors, DICTUC SA., Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolina López
iCenter for Aromas and Flavors, DICTUC SA., Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luis Méndez
jEndoscopy Unit, Hospital Padre Hurtado, Santiago, Chile
kDepartment of Gastroenterology, Clinica Alemana de Santiago, Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Javier Pizarro-Berdichevsky
lCenter for Innovation in Pelvic Floor, Hospital Sótero del Río, Santiago, Chile
mDepartment of Obstetrics and Gynecology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrés Finkelstein-Kulka
nDepartment of Otolaryngology, Clínica Alemana de Santiago, Santiago, Chile
oFaculty of Medicine, Clínica Alemana Universidad del Desarrollo, Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Solari
pDepartment of Clinical Laboratory, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolás Salas
bMillennium Institute for Foundational Research on Data (IMFD), Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro Bahamondes
bMillennium Institute for Foundational Research on Data (IMFD), Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martín Ugarte
bMillennium Institute for Foundational Research on Data (IMFD), Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo Barceló
bMillennium Institute for Foundational Research on Data (IMFD), Santiago, Chile
dInstitute for Mathematical and Computational Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcelo Arenas
bMillennium Institute for Foundational Research on Data (IMFD), Santiago, Chile
dInstitute for Mathematical and Computational Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile
qDepartment of Computer Science, School of Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: marenas@ing.puc.cl agosin@ing.puc.cl
Eduardo Agosin
cDepartment of Chemical and Bioprocess Engineering, School of Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile
iCenter for Aromas and Flavors, DICTUC SA., Santiago, Chile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: marenas@ing.puc.cl agosin@ing.puc.cl
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The infectiousness and presymptomatic transmission of SARS-CoV-2 hinder pandemic control efforts worldwide. Therefore, the frequency of testing, accessibility, and immediate results are critical for reopening societies until an effective vaccine becomes available for a substantial proportion of the population. The loss of sense of smell is among the earliest, most discriminant, and prevalent symptoms of COVID-19, with 75-98% prevalence when clinical olfactory tests are used. Frequent screening for olfactory dysfunction could substantially reduce viral spread. However, olfactory dysfunction is generally self-reported, which is problematic as partial olfactory impairment is broadly unrecognized. To address this limitation, we developed a rapid psychophysical olfactory test (KOR) deployed on a web platform for automated reporting and traceability based on a low-cost (about USD 0.50/test), six-odor olfactory identification kit. Based on test results, we defined an anosmia score –a classifier for olfactory impairment–, and a Bayesian Network (BN) model that incorporates other symptoms for detecting COVID-19. We trained and validated the BN model on two samples: suspected COVID-19 cases in five healthcare centers (n = 926; 32% COVID-19 prevalence) and healthy (asymptomatic) mining workers (n = 1, 365; 1.1% COVID-19 prevalence). All participants had COVID-19 assessment by RT-PCR assay. Using the BN model, we predicted COVID-19 status with 76% accuracy (AUC=0.79 [0.75 − 0.82]) in the healthcare sample and 84% accuracy (AUC=0.71 [0.63 − 0.79]) among miners. The KOR test and BN model enabled the detection of COVID-19 cases that otherwise appeared asymptomatic. Our results confirmed that olfactory dysfunction is the most discriminant symptom to predict COVID-19 status when based on olfactory function measurements. Overall, this work highlights the potential for low-cost, frequent, accessible, routine testing for COVID-19 surveillance to aid society’s reopening.

Competing Interest Statement

DICTUC SA. has interest in commercial application of the olfactory test. E.A. is an advisor for DICTUC SA. C.V. and C.L. are employed by DICTUC SA.

Clinical Trial

This prospective study was not performed under a clinical setting and thus it was not registered in internationally recognized trial registries.

Funding Statement

This work was funded by the Technological Adoption Fund SiEmpre from SOFOFA Hub (CORFO), and partially funded by ANID through the Millennium Science Initiative Program ICN17 002 to S.E., P.B. and M.A.; ANID Millennium Science Initiative Program NCN17 081 and ANID/FONDAP CIGIDEN 15110017 to EU; FONDECYT 1200146 to S.E; and FONDECYT de Iniciacion 11190871 to P.A.S.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The ethics committee of the Pontificia Universidad Catolica de Chile, who is the academic entity overseeing clinical studies in the UC-Christus health care centers, has approved the execution of this study. The conditions under which this study was approved are the following: 1. Patient personal data is private and will not be disclosed. 2. Patient clinical data must be anonymized for the study. 2. Patients are all informed about the features and application protocol of the olfactory test. All patients must sign the appropriate consent for a non-invasive medical test upon application.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • We have made some modifications to the article based on recent suggestions from scientific reviewers. The main results of the paper have not changed, but mainly additional supplementary information has been added to further support our findings.

Data Availability

The required data to reproduce the results of this study have been deposited in Mendeley Data and can be freely downloaded from the link provided.

http://dx.doi.org/10.17632/z4ktvcwfp6.2

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 31, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Improved screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Improved screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test
Susana Eyheramendy, Pedro A. Saa, Eduardo A. Undurraga, Carlos Valencia, Carolina López, Luis Méndez, Javier Pizarro-Berdichevsky, Andrés Finkelstein-Kulka, Sandra Solari, Nicolás Salas, Pedro Bahamondes, Martín Ugarte, Pablo Barceló, Marcelo Arenas, Eduardo Agosin
medRxiv 2021.01.18.21249821; doi: https://doi.org/10.1101/2021.01.18.21249821
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Improved screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test
Susana Eyheramendy, Pedro A. Saa, Eduardo A. Undurraga, Carlos Valencia, Carolina López, Luis Méndez, Javier Pizarro-Berdichevsky, Andrés Finkelstein-Kulka, Sandra Solari, Nicolás Salas, Pedro Bahamondes, Martín Ugarte, Pablo Barceló, Marcelo Arenas, Eduardo Agosin
medRxiv 2021.01.18.21249821; doi: https://doi.org/10.1101/2021.01.18.21249821

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (580)
  • Anesthesia (141)
  • Cardiovascular Medicine (1974)
  • Dentistry and Oral Medicine (253)
  • Dermatology (188)
  • Emergency Medicine (336)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (704)
  • Epidemiology (11138)
  • Forensic Medicine (8)
  • Gastroenterology (633)
  • Genetic and Genomic Medicine (3206)
  • Geriatric Medicine (310)
  • Health Economics (570)
  • Health Informatics (2056)
  • Health Policy (865)
  • Health Systems and Quality Improvement (793)
  • Hematology (311)
  • HIV/AIDS (688)
  • Infectious Diseases (except HIV/AIDS) (12753)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (320)
  • Medical Ethics (92)
  • Nephrology (339)
  • Neurology (3006)
  • Nursing (168)
  • Nutrition (466)
  • Obstetrics and Gynecology (592)
  • Occupational and Environmental Health (614)
  • Oncology (1566)
  • Ophthalmology (478)
  • Orthopedics (189)
  • Otolaryngology (267)
  • Pain Medicine (204)
  • Palliative Medicine (57)
  • Pathology (404)
  • Pediatrics (917)
  • Pharmacology and Therapeutics (387)
  • Primary Care Research (357)
  • Psychiatry and Clinical Psychology (2812)
  • Public and Global Health (5625)
  • Radiology and Imaging (1104)
  • Rehabilitation Medicine and Physical Therapy (637)
  • Respiratory Medicine (765)
  • Rheumatology (342)
  • Sexual and Reproductive Health (316)
  • Sports Medicine (291)
  • Surgery (351)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)